TEOSYAL® PURESENSE REDENSITY I (2x1ml)

Teosyal Puresense Redensity 1 (2x1ml) Main Ingredients and Device Properties

The main ingredients of Teosyal Puresense Redensity 1 (2x1ml) are:

• Amino acids: Arginine, Lysine, Isoleucine, Leucine, Threonine, Valine, Proline, and Glycine, which stimulate collagen production.
• Vitamins and minerals: B6, Zinc, and Copper, which improve vitality and health of the skin.
• Non-crosslinked hyaluronic acid (HA): A natural substance present in the skin, which improves volume and hydration.
• Lidocaine: A local anaesthetic for numbing the injection site and making the procedure comfortable.
• Antioxidants: Alpha Lipoic Acid, N-acetyl-L-cysteine, and Glutathione, which create a barrier against free radicals.

Device Properties:

• Concentration: 15 mg/ml of HA.
• Volume: 1ml per syringe.
• Sterile and single-use: For maximum hygiene and safety.

Package Contains

The Teosyal Puresense Redensity 1 (2x1ml) package contains:

• 2 pre-filled syringes of 1 ml each
• 4 sterile 30G1/2” needles
• Package insert with instructions
• Traceability labels.

Storage Conditions

Proper storage of Teosyal Puresense Redensity 1 (2x1ml) is crucial to maintain its efficacy and safety. Here are the recommended storage conditions for this dermal filler:

• Store between 2°C and 25°C.
• Keep the product in its original packaging.
• Protect from direct sunlight and freezing.
• Keep out of reach of unauthorised personnel.

Mode of Administration

Administering Teosyal Puresense Redensity 1 (2x1ml) involves several steps to ensure optimal results and patient safety.

Before the treatment

• Conduct a thorough patient assessment and obtain a medical history.
• Cleanse the treatment area with an antiseptic solution.
• Apply a topical anaesthetic if necessary.

During the treatment

• Use a sterile 30G1/2” needle provided in the package.
• Inject the product slowly into the mid-dermis or superficial dermis.
• Distribute the product evenly to achieve the desired effects.
• Massage the treated area gently to ensure even distribution.

After the treatment

• Observe the patient for any immediate adverse reactions.
• Provide post-treatment care instructions.
• Schedule follow-up appointments as needed.

Post-Treatment Care

Proper post-treatment care is essential for achieving the best results and minimising side effects. Here are the recommended guidelines for patients:

• Avoid exposure to extreme temperatures (hot or cold) for at least 24 hours.
• Refrain from extreme exercise for the first 24 hours.
• Do not apply makeup to the treated area for at least 12 hours.
• Avoid direct sunlight and use at least SPF50 sunscreen.
• Do not massage or rub the treated area for the first 24 hours.
• Stay hydrated and maintain a healthy skincare routine.

Benefits and Results of Using Teosyal Puresense Redensity I (2x1ml)

Teosyal Products have many benefits, the most prominent ones are as follows:

• Deeply hydrates the skin
• Improves skin firmness and elasticity
• Reduces the appearance of fine lines and wrinkles
• Quick recovery and minimal downtime
• Enhances skin radiance and glow
• Provides long-lasting results
• Ensures a comfortable treatment with lidocaine
• Gives natural and subtle results
• Improves mental health by boosting self-esteem.

Potential Side Effects

Like all medical procedures, treatment with Teosyal Puresense I (2x1ml) may cause potential side effects. The common ones include:

• Bruising
• Itching
• Tenderness
• Swelling
• Redness at the injection site.

Rare side effects are uncommon but should they occur, patients should seek medical attention. These include: 

• Necrosis (extremely rare)
• Infection
• Persistent swelling or pain
• Lumps or nodules
• Allergic reactions
• Granulomas
• Discoloration.

Contraindications for the Treatment

Some patients may not be suitable for the treatment with Teosyal Puresense Redensity I (2x1ml):

• Individuals with known allergies to hyaluronic acid or lidocaine
• Individuals who have a history of severe allergic reactions
• Pregnant or breastfeeding women
• Individuals with unstable medical conditions
• Patients on immunotherapy
• Individuals with autoimmune diseases
• Patients with skin infections or inflammations
• Persons who had skin procedures recently
• Patients with blood clotting disorder.

Medical professionals should examine their patients before the treatment to assess whether they are suitable for the procedure.